The Innovator IBD Breakout Opportunities ETF (BOUT) top stock holdings include Enliven Therapeutics, Glaukos, and Bicara Therapeutics. The top 25 BOUT holdings ordered by weight make up 99.87% of the total fund. BOUT is an equity fund in the broad equity category that invests in publicly traded companies and other investments, focused on strategy strategies within the North America region. This page includes a complete BOUT stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.
Top 25 BOUT Holdings
BOUT Geographic Exposure
BOUT's largest geographic exposure is United States at 75.9%, followed by Israel at 6.3%.
BOUT Currency Exposure
BOUT is exclusively exposed to USD.
BOUT Sector Exposure
BOUT's largest sector exposure is Health Care at 34.6%, followed by Financials at 28.2%.
BOUT Industry Exposure
BOUT's largest industry exposure is Biotechnology at 23.7%, followed by Banks at 20.9%.
Diversified Consumer Services
Textiles, Apparel & Luxury Goods
Semiconductors & Semiconductor Equipment
Health Care Providers & Services
BOUT Sub-Industry Exposure
BOUT's largest sub-industry exposure is Diversified Banks at 18.8%, followed by Biotechnology at 18.7%.
Apparel, Accessories & Luxury Goods
Electrical Components & Equipment
Asset Management & Custody Banks